These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Transplantations of frozen-thawed ovarian tissue demonstrate high reproductive performance and the need to revise restrictive criteria. Meirow D, Ra'anani H, Shapira M, Brenghausen M, Derech Chaim S, Aviel-Ronen S, Amariglio N, Schiff E, Orvieto R, Dor J. Fertil Steril; 2016 Aug; 106(2):467-74. PubMed ID: 27181924 [Abstract] [Full Text] [Related]
3. Thirteen years' experience in fertility preservation for cancer patients after in vitro fertilization and in vitro maturation treatments. Creux H, Monnier P, Son WY, Buckett W. J Assist Reprod Genet; 2018 Apr; 35(4):583-592. PubMed ID: 29502188 [Abstract] [Full Text] [Related]
9. Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies. Meirow D, Raanani H, Maman E, Paluch-Shimon S, Shapira M, Cohen Y, Kuchuk I, Hourvitz A, Levron J, Mozer-Mendel M, Brengauz M, Biderman H, Manela D, Catane R, Dor J, Orvieto R, Kaufman B. Fertil Steril; 2014 Aug; 102(2):488-495.e3. PubMed ID: 24934489 [Abstract] [Full Text] [Related]
10. Long term pregnancy outcomes of women with cancer following fertility preservation: A systematic review and meta-analysis. Xu Z, Ibrahim S, Burdett S, Rydzewska L, Al Wattar BH, Davies MC. Eur J Obstet Gynecol Reprod Biol; 2023 Feb; 281():41-48. PubMed ID: 36535069 [Abstract] [Full Text] [Related]
14. Live birth rate after use of cryopreserved oocytes or embryos at the time of cancer diagnosis in female survivors: a retrospective study of ten years of experience. Mayeur A, Puy V, Windal V, Hesters L, Gallot V, Benoit A, Grynberg M, Sonigo C, Frydman N. J Assist Reprod Genet; 2021 Jul; 38(7):1767-1775. PubMed ID: 33797007 [Abstract] [Full Text] [Related]
16. Modeling of live-birth rates and cost-effectiveness of oocyte cryopreservation for cancer patients prior to high- and low-risk gonadotoxic chemotherapy. Lyttle Schumacher B, Grover N, Mesen T, Steiner A, Mersereau J. Hum Reprod; 2017 Oct 01; 32(10):2049-2055. PubMed ID: 28938728 [Abstract] [Full Text] [Related]
17. Experiences in fertility preservation: lessons learned to ensure that fertility and reproductive autonomy remain options for cancer survivors. Noyes N, Melzer K, Druckenmiller S, Fino ME, Smith M, Knopman JM. J Assist Reprod Genet; 2013 Oct 01; 30(10):1263-70. PubMed ID: 23942892 [Abstract] [Full Text] [Related]